Friday, August 3, 2012


Tweeting for Student Health Care Coverage

  • FACEBOOK
  • TWITTER
  • GOOGLE+
  • E-MAIL
  • SHARE
  • PRINT
An Arizona graduate student with advanced colon cancer turned to Twitter when his insurance company stopped covering his medical bills. Surprisingly, the insurance company’s chief executive responded.
Arijit Guha turned to social media to help raise money for the treatment of his colon cancer.Arijit Guha turned to social media to help raise money for the treatment of his colon cancer.
What ensued was a fiery multiday exchange that not only resulted in full coverage of the student’s medical bills, but cast light on gaps in student health care coverage and the complexities of the country’s private insurance system.
THE AGENDA: HEALTH
The rising costs of the U.S. health care system.
Arijit Guha, 31, a New York native who was raised in Ohio, learned he had cancer in February 2011 after developing debilitating stomach pain following a trip to India. During surgery, the doctors found the cancer had spread to his abdominal lining, and they removed most of his colon, leaving him with a colostomy. Since then he has undergone more surgery and chemotherapy or, in his words, been “filleted, disemboweled and then bathed in hot poison.”
Mark T. Bertolini, Aetna’s C.E.O.Aetna Inc., via Associated PressMark T. Bertolini, Aetna’s C.E.O.
A doctoral student at Arizona State University, Mr. Guha was insured under an Aetna Student Health plan for which he paid $400 a month. The plan initially covered his care, but in February, Mr. Guha’s treatment costs reached the $300,000 cap on the insurance plan, leaving the student with $118,000 in medical bills.
More than a million students are covered through college health plans, according to the federal Department of Health and Human Services. Although the Affordable Care Act does away with coverage caps, the rules are still being phased in and don’t yet apply to all student health plans.
When Aetna began denying his claims, Mr. Guha took his frustrations to Twitter. Using the Twitter handle @Poop_Strong, he posted his first message on July 22.
@Aetna has now denied $118k in claims (in just 5 mos) since kicking me to the curb. Gotta preserve that $2 billion annual profit somehow.
The insurance company responded under the Twitter name @AetnaHealth, and asked Mr. Guha to contact someone there.
@Poop_Strong We care about our members. We want you to be empowered to be healthy and make informed decisions.
But Mr. Guha said the word “empowered” made him angry, and he posted a sarcastic response, invoking the Aetna chief executive, Mark T. Bertolini,whose Twitter account is @mtbert.
That’s so sweet you want me to be empowered. Does @mtbert care to empower me by paying my $118K and counting in bills?
Then a startling thing happened. Mr. Bertolini entered the fray himself on July 26.
We paid hundreds of thousands of $ already. A call is all it takes.
Mr. Guha responded:
Does that mean if I call you, you’ll graciously offer to pay my bills?
The surprising exchange continued, and Mr. Guha challenged Mr. Bertolini to defend Aetna’s student health care plans with limited caps.
@mtbert Do you think it’s morally justifiable to offer a flawed insurance product that doesn’t cover catastrophes?
Mr. Bertolini responded:
@poop_strong Why do you think the premiums were so low? Don’t you look at your policy limits when you buy other insurance (auto)?
The response angered Mr. Guha and his followers, who jumped in. A follower named @Amayo wrote:
@mtbert I’m concerned that you don’t understnad how your industry works. ASU students aren’t given a choice on insurance plans
And @ponderbob sent this message:
@mtbert As a dad, if your kid was in school, got cancer & reached their lifetime cap, what advice would you give him?
The floodgates opened, and Mr. Guha’s friends — and a few people he didn’t know — joined in, aiming barbs at Mr. Bertolini and attacking the insurance industry. “Things got heated pretty quickly,” Mr. Guha acknowledged. “People were taking this pretty personally, especially people who know me.”
After Mr. Bertolini mentioned that the insurance giant’s $2 billion in earnings would cover only 10 percent of the uninsured, a Twitter user named @sean_dougall responded:
@mtbert Nobody’s asking you to cover the uninsured. We’re asking you to cover your members.
In what seemed to be a turning point, Mr. Bertolini noted that he was working to help Mr. Guha.
The system is broken. I’m trying to fix it.
On Friday, Mr. Bertolini called Mr. Guha directly. Aetna agreed to cover the $118,000 in bills. More important, Aetna and the university now will offer a student plan for the 2012-13 academic year with no lifetime cap and a $2 million annual cap that will eventually disappear under the Affordable Care Act. The policy also will cover preventive care for students and won’t deny anyone with a pre-existing condition.
“We wanted to be proactive about meeting students’ needs,” said Dr. Allan Markus, the director of health services at Arizona State and one of Mr. Guha’s doctors. Dr. Markus said that Mr. Guha was the first A.S.U. student he has known who has reached the $300,000 lifetime cap.
So what drove Mr. Bertolini’s involvement? “This was a compelling case,” he said in an e-mail. “This felt like a discussion I should be involved in. I appreciated the conversation, even when it was pointed.”
Mr. Bertolini said he is a regular Twitter user “because I enjoy it.” He added that as chief executive, he believes Twitter is an essential tool for him to interact with his customers. “It is where people are talking about issues that are important to them,” he said. “We must be part of that dialogue if we want to be a viable player.”
“I was pleased we found a resolution, working with the school, to help him,” he said.
Before winning coverage from Aetna, Mr. Guha had initiated a social media fund-raising campaign to help pay his bills. Now he plans to donate the estimated $130,000 he raised to charities that help support cancer patients.
Mr. Guha is currently on a break from biweekly chemotherapy treatments after a successful procedure to remove a lesion on his liver in April. He says he wants to become more involved in health policy activism.
Mr. Guha announced the resolution to his financial problems on Twitter.
“Congrats Twitter hordes! @Aetna has agreed to cover my bills. Every last penny. Thanks, @mtbert, for listening.”
Mr. Guha has nothing but praise for Mr. Bertolini. “In the end, he did the right thing,” he said. “Now the fight moves on to ensuring this never needs to happen for anyone ever again.”

Over the coming weeks, Well will continue to explore the reasons behind our troubled health care system from the perspective of the patient. The series will be part of a larger New York Times project called The Agenda, which will focus on some of the most critical issues that the president and the next Congress will face in the coming months and years. Join the conversation at The Agenda
  • FACEBOOK
  • TWITTER
  • GOOGLE+
  • E-MAIL
  • SHARE
  • PRINT

Related Articles Also Tagged:

Saturday, July 28, 2012

Brittany Wenger, 17, Wins Google Science Fair Grand Prize For Breast Cancer Diagnosis App

https://sites.google.com/a/googlesciencefair.com/science-fair-2012-project-64a91af142a459cfb486ed5cb05f803b2eb41354-1333130785-87/home


Project Summary

Global Neural Network Cloud Service for Breast Cancer

Global Neural Network Cloud Service for Breast Cancer

Leveraging the computing power of the cloud to assist with medical diagnosis can become an effective tool for doctors to provide more consistent and reliable care.  Artificial neural networks detect patterns too complex to be recognized by humans and can be applied to breast mass malignancy classification when evaluating Fine Needle Aspirates (FNAs).  This project teaches the cloud how to diagnose breast cancer by implementing a custom-crafted neural network that consumes FNA data collected by the University of Wisconsin to answer the question – is a mass malignant or benign?
Medical usage demands neural networks achieve accuracy with their diagnosis and reduce malignant false negatives. Building on data collected by the University of Wisconsin in the early 1990s, this project first evaluates three modern commercial neural network implementations. Information regarding potential indicators of breast cancer is quantified in the dataset; specifically, clump thickness, single epithelial cell size, bare nuclei, mitoses, and five other attributes. Each network accepts this input to optimize its hidden nodes and is tested with ten trials. With each trial, a randomly selected 10% of the dataset is used to assess the predictive power of the constructed neural network. These commercially created neural networks serve as a control group.
Development of a custom neural network weights malignant false negatives and allows for the identification of inconclusive samples (capacities not available in commercial products.)  Additionally, more samples are needed to improve the predictive capability of the network; therefore, the network has been published in the cloud, allowing for global submissions and benefit.  The cloud service is hosted in the Google App Engine.
The successfully implemented custom network is tested with 6,800 trials.  To assure maximum training, each sample is run through ten trials evaluated by different networks trained against all other samples.  The custom neural network achieved predictive success of 97.4% with 99.1% sensitivity to malignancy – substantially better than the evaluated commercial products.  Out of the commercial products, two experienced consistent success while the third experienced erratic success. The sensitivity to malignancy for the custom network was 5% higher than the best commercial network’s sensitivity. This experiment demonstrates modern neural networks can handle outliers and work with unmodified datasets to identify patterns. In addition, when all data is used for training, the custom network achieves 100% success with only 4 inconclusive samples, proving the network is more effective with more samples.  Additionally, 7.6 million trials were run using different training sample sizes to demonstrate the sensitivity and predictive success improves as the network receives more training samples.
The Global Neural Network Cloud Service for Breast Cancer may be ready to diagnose actual patients – more global participation is required to confirm the findings and increase the predictive success on blind samples.


An avid student, volunteer, athlete, and researcher, I am driven to learn and understand. I have never outgrown the “why” phase. I question everything, and it wasn’t until I was introduced to science that I found answers -- and, more questions. My elementary school experiences developed my passion for experimentation.
My enthusiasm for science continues to blossom. Helping find the cure to cancer is a goal of mine. I have experienced the pain of family members inflicted with the disease and have witnessed the anguish in Georgetown's pediatric cancer ward. Going forward, I seek to learn as much as I can in the computer science and medical fields to help achieve this goal. Although only a high school junior, I am top in my class and participate in the most rigorous courses offered at my school. I expect to major in computer science when I attend college and continue to medical school.

WWSB ABC 7 Interview

 
Minor Planet, 25333, named britwenger
Awards do not define me; however, they validate my scientific research.  With each year, my research increases in complexity and has more potential to have positive benefit on mankind.  When I was presented with the naming of minor planet 25333 by MIT Lincoln Laboratory, I was in disbelief; however, getting recognized by some of the top world scientists drives me to work harder.  Together, we can solve extraordinary challenges.
Winning the Google Science Fair and interacting with the top scientists at Google would be an awe-inspiring opportunity for me.

Tuesday, July 24, 2012

Survive Cancer, Raise the Kids, Get to Work, Cook, Clean, Workout, Repeat...



Adding Cancer Survival to the 'To Do' List

Gone are the days when you take a day off when you are sick. It is no longer enough to rest and recuperate, we don't have time for that. If we have a cold, we take Nyquil to sleep, and some other pill to get us through the work day.
But we expect that this won't be the case for major illnesses, especially cancer. We imagine there is time to recover, to reflect, to process, but the reality is quite different, especially if you are a parent responsible for small children.
Because of advances in medicine, many procedures that diagnose, and treat cancer are out-patient. There is no time to be cared for, you go in, get poked and prodded, then head home to take on the other chores of life. Your doctor says, with a smile, that you can return to work.
But we don't want to return to work. We need a break.
The process is too often like this:
- the cancer is discovered, either a lump is felt, or it shows up in some screening (what is not documented at this time, as that we go back to work, pick up the kids, cook dinner, go on)
- a biopsy indicates the cancer is malignant and treatment options are discussed (we rush from doctor to doctor, they give us their opinions, maybe we get second opinions, all during breaks at work - holding back our own pain, swinging by the grocery store on the way home)
- treatment begins. We are exhausted, and nauseous. We still make it in for work. We don't think we are doing a very good job. We feel sick, we feel unattractive... we go home, and don't feel like a very good parent.
- treatment ends. We are still tired, maybe more so because treatment can have a cumulative effect. We are used to seeing our doctors every day, but now we have this void. All of the professionals who are there to help us fade away - and we are back in the role of parent, employee... someone other people rely on.
This is just the reality of surviving cancer in the modern day.
Cancer is no longer a death sentence. That's a good thing!! But it also has become an outpatient procedure, in spite of the difficult physical hurdles to overcome, and emotional trauma to process. Somehow, we are expected to continue on with our lives, thankful to be alive (and we are), but also expected to keep pace with the rest of the world.
What can cancer survivors do to find balance? How can a cancer survivor nurture themselves, and still take care of their families and keep their job?
1) Reset priorities. This can be anything, but your priorities should be meaningful to you. Write them down if necessary. If your children are a priority, this doesn't mean you have to give into their every whim, but that you choose to set aside quality time for them. If work is a priority, you can forgive yourself if you are late, as long as you are proud of the work you do. We can't do everything, every day. But we can do a few meaningful things.
2) Take 15 minutes in the morning and at night, and write in a journal. In the morning, start the day with a sense of new beginnings. Think of all the possibilities. Think of things you'd like to accomplish (again, one or two meaningful things, not an overwhelming 'to do' list), but also think of at least ONE thing that you will do to nurture yourself. This can be a simple walk in the fresh air during your lunch break, or a cup of tea with a friend. Find some time during the day to do something that brings you personal joy. In the evening, remember your accomplishments. Be proud that you are doing so well (it truly is remarkable all that we accomplish). Remember our children's successes. Forgive yourself for anything that is left undone and celebrate the special moments of that day.
3) A few days a week, fit in an activity that connects your body and mind and the world around you. One of the best ways to do this, for cancer survivors, is through yoga. The deep breathing, and mental focus in yoga has numerous benefits for stress reduction, the immune system, overall health and well-being. But any form of exercise that you enjoy will have similar benefits: walking, hiking, tennis, swimming, paddling... you feel better physically, and have improved mental clarity.
Your children will see you at peace and will learn and grow and be inspired by your strength. They don't need a gourmet meal every night, they want your love and attention. Your employer (whether they tell you or not) is simply amazed at your strength and dedication.
Don't worry about doing it all. The life of a cancer survivor, is a life moving toward balance.

Understanding Cancer Biopsies


A biopsy is a procedure to remove a piece of tissue or a sample of cells from your body so that it can be analyzed in a laboratory. If you're experiencing certain signs and symptoms or if your doctor has identified an area of concern, you may undergo a biopsy to determine whether you have cancer or some other condition.

If it is a solid tumor, your biopsy choices can affect your survival. Read the information following these descriptions of various biopsies to understand your choices.

Bone marrow biopsy

Your doctor may recommend a bone marrow biopsy if an abnormality is detected in your blood or if your doctor suspects cancer has traveled to your bone marrow. Bone marrow is the spongy material inside some of your larger bones where blood cells are produced. Analyzing a sample of bone marrow may reveal what's causing your blood problem.
During a bone marrow biopsy, your doctor draws a sample of bone marrow out of the back of your hipbone using a long needle. In some cases, your doctor may biopsy marrow from other bones in your body. Bone marrow biopsy is commonly used to diagnose a variety of blood problems — both noncancerous and cancerous, including blood cancers, such as leukemia, lymphoma and multiple myeloma. You receive a local anesthetic before a bone marrow biopsy in order to minimize discomfort during the procedure.

Endoscopic biopsy

During endoscopy, your doctor uses a thin, flexible tube with a light on the end to see structures inside your body. Special tools are passed through the tube to take a small sample of tissue to be analyzed.
What type of endoscopic biopsy you undergo depends on where the suspicious area is located. Tubes used in an endoscopic biopsy can be inserted through your mouth, rectum, urinary tract or a small incision in your skin. Examples of endoscopic biopsy procedures include cytoscopy to collect tissue from the inside of your bladder, bronchoscopy to get tissue from inside your lung and colonoscopy to collect tissue from inside your colon.
Depending on the type of endoscopic biopsy you undergo, you may receive a sedative or anesthetic before the procedure.

Needle biopsy

During a needle biopsy, your doctor uses a special needle to extract cells from a suspicious area. A needle biopsy is often used on tumors that your doctor can feel through your skin, such as suspicious breast lumps and enlarged lymph nodes. When combined with an imaging procedure, such as X-ray, needle biopsy can be used to collect cells from a suspicious area that can't be felt through the skin.
Needle biopsy procedures include:
Fine-needle aspiration. During fine-needle aspiration, a long, thin needle is inserted into the suspicious area. A syringe is used to draw out fluid and cells for analysis.
Core needle biopsy. A larger needle with a cutting tip is used during core needle biopsy to draw a column of tissue out of a suspicious area.
Vacuum-assisted biopsy. During vacuum-assisted biopsy, a suction device increases the amount of fluid and cells that is extracted through the needle. This can reduce the number of times the needle must be inserted to collect an adequate sample.
Image-guided biopsy. Image-guided biopsy combines an imaging procedure, such as X-ray, computerized tomography (CT), magnetic resonance imaging (MRI) or ultrasound, with a needle biopsy. Image-guided biopsy allows your doctor to access suspicious areas that can't be felt through the skin, such as abnormalities on the liver, lung or prostate. Using real-time images, your doctor can make sure the needle reaches the correct spot.
You'll receive a local anesthetic to numb the area being biopsied in order to minimize the pain.

Skin biopsy

A skin (cutaneous) biopsy removes cells from the surface of your body. A skin biopsy is used most often to diagnose skin conditions, including cancers, such as melanoma. What type of skin biopsy you undergo will depend on the type of cancer suspected and the extent of the suspicious cells. Skin biopsy procedures include:
Shave biopsy. During a shave biopsy, the doctor uses a tool similar to a razor to scrape the surface of your skin.
Punch biopsy. During a punch biopsy, the doctor uses a circular tool to remove a small section of your skin's deeper layers.
Incisional biopsy. During an incisional biopsy, the doctor uses a scalpel to remove a small area of skin. Whether you receive stitches to close the biopsy site depends on the amount of skin removed.
Excisional biopsy. During an excisional biopsy, the doctor removes an entire lump or an entire area of abnormal skin. You'll likely receive stitches to close the biopsy site.
You receive a local anesthetic to numb the biopsy site before the procedure.

Surgical biopsy

If the cells in question can't be accessed with other biopsy procedures or if other biopsy results have been inconclusive, your doctor may recommend a surgical biopsy. During a surgical biopsy, a surgeon makes an incision in your skin to access the suspicious area of cells. Examples of surgical biopsy procedures include surgery to remove a breast lump for a possible breast cancer diagnosis and surgery to remove a lymph node for a possible lymphoma diagnosis.
Incisional biopsy. During an incisional biopsy, the doctor uses a scalpel to remove part of an abnormal area of cells.
Excisional biopsy. During an excisional biopsy, the doctor removes an entire lump or an entire area of abnormal cells.
You may receive local anesthetics to numb the area of the biopsy. Some surgical biopsy procedures require general anesthetics to make you unconscious during the procedure. You may also be required to stay in the hospital for observation after the procedure.
Source of Biopsy descriptions listed above: Mayo Clinic

Choices in Biopsy that Affect Survival

Some biopsies are determined by the type of cancer indicated by the symptoms. Blood cancers are best diagnosed by sampling the bone marrow.
Cancers with solid tumors, like a breast cancer, are often biopsied with a Needle Biopsy or Surgical Biopsy. Your surgeon may encourage a Needle Biopsy because it is a simpler outpatient procedure, but this may not be the best option for you.
While the idea of a full Excisional Biopsy via surgery may seem scary at first, if it is an option for you, that will be the ONLY way to make sure you get all the cancer cells from this tumor OUT OF YOUR BODY.
A Needle Biopsy, or a Incisional (or partial) Biopsy can break off stray cancer cells that can begin to migrate. Since most people don't die from the initial cancer, they die from metastatic cancer (cancer that has spread), you want to do everything you can to prevent this from happening. The best way to do this, with a solid tumor, is to remove the entire tumor if possible.
If you have a solid tumor, you can begin your fight against cancer at the biopsy stage. Surgery may seem scary, but it's worth it.

Friday, July 20, 2012

600-Year-Old Bras Uncovered in Austrian Castle


By Anthony Castellano
Jul 19, 2012 7:54am


ap innsbruck bra dm 120719 wblog 600 Year Old Bras Uncovered in Austrian Castle
                       (Image Credit: University Innsbruck Archeological Institute/AP Photo)
Victoria’s Secret might get credit for reinventing the brassiere, but the earliest-known bras now date back to the Middle Ages,  according to Austrian archeologists at the University of Innsbruck.
The university said Wednesday that it found four linen bras in an Austrian castle dating back to the 1400s, proving that women wore bras more than 600 years ago. It’s such a revolutionary find because fashion experts thought the modern-day bra was only about 100 years old after women became tired of tight corsets.
One specimen in particular “looks exactly like a [modern] brassiere,” Hilary Davidson, fashion curator for the London Museum, told The Associated Press. “These are amazing finds.”
Some of the ancient bras were intricately decorated with lace, suggesting that they were meant to be seen by someone else other than the person wearing it.
Although the linen garments were discovered in 2008, they did not make news until now, says Beatrix Nutz, the archaeologist responsible for the discovery. Researchers said the bras underwent carbon dating and they had to make sure the look of the bras fit with the 1400s.
“We didn’t believe it ourselves,” Nutz said. “From what we knew, there was no such thing as bra-like garments in the 15th century.”
Among the more than 2,700 textile fragments that were found in the Lemberg Castle in Tyrol was a linen undergarment that looks like a pair of panties. Nutz said it is men’s underwear because women did not wear anything under their flowing skirts in the Middle Ages.
Women started experimenting with bra-like garments in the 1800s, but it wasn’t until when the modern-day brassier was invented by Mary Phelps Jacob, who received a patent for her bra in 1914.

Thursday, July 19, 2012

BREAST CANCER OCCURENCE, DIAGNOSIS AND MORTALITY STATISTICS

http://www.maurerfoundation.org/breast-cancer-occurrence-diagnosis-mortality-statistics/3978
African-American women are more likely to die from breast cancer, above non-Hispanic white women, Hispanic/Latina, American Indian/Alaska native, and Asian-American/Pacific Islander groups.
With so much information and studies available on breast cancer, it can be a bit overwhelming to get a grasp on how breast cancer is really effecting us as a nation. Here is a run-down of the most recent trends and statistics on the diagnosis of breast cancer based on gender, age and race/ethnicity, as well as survivability figures.

  • Breast cancer is second only to lung cancer in the number of cancer deaths.
  • Excluding skin cancer, breast cancer is the most common cancer in women.
  • 1 in 3 cancers diagnosed in U.S. women is breast cancer.

  • Between 1980 and 1987, there was a rapid increase in breast cancer incidence, most likely as a result of increased mammogram rates.
  • Breast cancer incidence rates stabilized in the 1990′s, and then slowly increased in the late 1990′s, most likely as a result of further increases in mammograms, increased obesity rates, and increased use of menopausal hormone therapy.
  • Between 2002 and 2003, breast cancer incidence rates dropped sharply (7%), likely as a result of decreased used of menopausal hormone therapy as well as a decreasing mammogram rate.
  • Since 2003, breast cancer rates have remained relatively stable.
  • 5-year survival rates for breast cancer have steadily increased since 1975.
  • Breast cancer rates for women under 50 have remained stable since 1985.
  • Breast cancer rates for women over 50 have remained stable since 2003, which a peak of diagnosis rates in the late 1990′s.
  • Starting in the 1980′s, mortality rate of African-American women from breast cancer began to diverge from non-Hispanic white women. By 2007, African-American women had a 41% higher mortality than non-Hispanic white women.
  • Death rates for men with breast cancer have declined 3.3% per year since 2000.
  • 1975-2008, breast cancer incidence rate in men increased 0.8% annually.

  • Women—An estimated 230,480 will be diagnosed with invasive breast cancer and an estimated  39,520 women will die in 2011.
  • Men—An estimated 2,150 will be diagnosed with breast cancer and an estimated 450 men will die in 2011.
  • An estimated 1% of all diagnosed cases will occur in men in 2011.

  • Women under 40—An estimated 11,300 will be diagnosed with invasive breast cancer and an estimated 1,160 women will die in 2011.
  • Women under 50—An estimated 50,430 will be diagnosed with invasive breast cancer and an estimated 5,240 women will die in 2011.
  • Women 50-64—An estimated 81,970 will be diagnosed with invasive breast cancer and an estimated 11,620 women will die in 2011.
  • Women 65 and older—An estimated 98,080 will be diagnosed with invasive breast cancer and an estimated 22,660 women will die in 2011.
  • 95% of breast cancer diagnoses occur in women over 40 years old.
  • 97% of breast cancer deaths occur in women over 40 years old.
  • During 2004-2008, women aged 20-24 had a breast cancer incidence rate of 1.5 cases per 100,000 women.
  • During 2004-2008, women aged 75-79 had the highest incidence rate of breast cancer diagnosis.
  • During 2004-2008, the median age for female breast cancer diagnosis was 61 years old.
  • 50% of women diagnosed with breast cancer were 61 years or younger, between 2004 and 2008.
  • 1 in 8 women will be diagnosed with breast cancer during her lifetime.

  • Non-Hispanic white women in the U.S. have an incidence rate of 125.4 cases per 100,000, the highest of all races and ethnicities, and a mortality rate of 23.9 per 100,000, the second highest of all races and ethnicities.
  • African-American women in the U.S. have an incidence rate of 116.1 cases per 100,000, the second highest of all races and ethnicities, and a mortality rate of 32.4 per 100,000, the highest of all races and ethnicities.
  • Hispanic/Latina women in the U.S. have an incidence rate of 91.1 cases per 100,000, and a mortality rate of 15.3 per 100,000.
  • American Indian/Alaska native women in the U.S. have an incidence rate of 89.2 cases per 100,000, and a mortality rate of 17.6 per 100,000.
  • Asian-American/Pacific Islander women in the U.S. have an incidence rate of 84.9 cases per 100,000, and a mortality rate of 12.2 per 100,000, both rates the lowest of all ethnic and racial groups.
  • Before the age 40, African-American women have a higher incidence of breast cancer than non-Hispanic white women.
  • African-American women are more likely to die from breast cancer, above non-Hispanic white women, Hispanic/Latina, American Indian/Alaska native, and Asian-American/Pacific Islander groups.
  • Incidence rate in men is higher for African-American men than other races and ethnicities.

  • Women with breast cancer have a 99% 5-year survival rate if it is localized, 84% if it is regional, and 23% if it is distant-stage.
  • Larger tumors reduce 5-year survival rate.
  • The 5-year survival rate for African-American women is 77% and 90% for white women.
  • African-American women have the greatest chance of all ethnicities to die of breast cancer. This is likely as a result of the more aggressive tumors common in African-American women, higher rate of proverty, and later stage of detection.
  • Obese women diagnosed with breast cancer have a 30% higher mortality rate than breast cancer patients that maintain a healthy weight.
  • Women diagnosed with breast cancer that is not estrogen responsive (ER+) or progesterone responsive (PR+) have a 1.5-2 times higher rate of mortality.
  • Women from lower income areas have a lower 5-year survival rate than women from higher income areas.

Reduce your chances of being diagnosed by educating yourself on the risk factors of breast cancer and taking action on the factors you have control of like smoking and obesity. Later stage detection and advanced tumor size decrease your odds of surviving breast cancer. Improve your odds of survival by practicing early detection. Do a monthly breast self-exam, a yearly clinical breast exam, and after 40 a yearly mammogram. Empower yourself and improve your odds.
(Source: “Breast Cancer Facts & Figures: 2011-2012,” American Cancer Society, www.cancer.org)